BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3223452)

  • 1. [Inhibitory effect of CG-120 on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1988 Jun; 34(6):1073-6. PubMed ID: 3223452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The inhibitory effects of Takusha on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Kawamura K; Moriyama M; Nakajima C; Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1993 Aug; 39(8):695-700. PubMed ID: 8379469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
    Suzuki K; Miyazawa K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of kanpou medicine on the growth and aggregation of calcium oxalate crystals in vitro].
    Utsunomiya M; Koide T; Yamaguchi S; Yoshioka T; Sonoda T; Sugiyama K
    Hinyokika Kiyo; 1991 Oct; 37(10):1097-101. PubMed ID: 1755397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effect of oral administration of Takusya on calcium oxalate crystallization in human whole urine].
    Honda M; Yoshimura K; Miyake O; Yoshioka T; Okuyama A; Yamaguchi S; Utsunomiya M; Koide T; Sugiyama K
    Hinyokika Kiyo; 1997 May; 43(5):333-7. PubMed ID: 9208316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
    Grover PK; Ryall RL
    Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent assessment of the growth and aggregation of calcium oxalate crystals using the Coulter counter.
    Ryall RL; Bagley CJ; Marshall VR
    Invest Urol; 1981 Mar; 18(5):401-5. PubMed ID: 7203965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
    Worcester EM; Nakagawa Y; Coe FL
    Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
    Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
    J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium oxalate dihydrate crystal growth.
    Werness PG; Duckworth SC; Smith LH
    Invest Urol; 1979 Nov; 17(3):230-3. PubMed ID: 40922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
    Suzuki K; Tsugawa R
    Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The development of continuous crystallizer and observation of formation and growth of calcium oxalate crystals].
    Suzuki K; Domiki C; Tsugawa R
    Hinyokika Kiyo; 1991 Jun; 37(6):569-75. PubMed ID: 1716408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlations between the metastable solutions of calculus-forming salts and crystals from coexistent insoluble urinary components].
    Leskovar P; Hartung R
    Z Urol Nephrol; 1978 Sep; 71(9):601-11. PubMed ID: 716644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary glycosaminoglycans are selectively included into calcium oxalate crystals precipitated from whole human urine.
    Suzuki K; Mayne K; Doyle IR; Ryall RL
    Scanning Microsc; 1994; 8(3):523-30. PubMed ID: 7747154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.